scattered pattern involving mainly the bone marrow, liver, spleen and lymph nodes.' However, the compact localization of these cells forming tumor masses is a rare occurrence.
It has been well documented that patients with
Waldenstrom's macroglobulinemia5~~ are predisposed to a variety of pulmonary infections. However, tumor formation by the neoplastic cells in the lungs is indeed a rare presentation. McCallister and colleag~es'~ review of 227 cases did not include any such instance. Furgerson et a18 reported an autopsy case with pulmonary involvement consisting of h e nodular infiltrates, as well as large areas of confluent infiltration of the lungs due to proliferation of plasmacytoid neoplastic cells, similar plasmacytoid cells being seen in the bone marrow. Moeschlin8 also documented a case of pulmonary involvement by antemortem lung biopsy also with marrow involvement. Recently, Rabiner et all0 reported a patient with early bronchial and pulmonary involvement with negative bone marrow. In the few previously reported cases of pulmonary tumor in Waldenstrom's macroglobulinemia and in the present one, histopathologic findings disclosed the classic spectrum of the neoplastic lymphoproliferative cells, the predominant lymphocytoid plasmacyte, other types of lymphocytes, plasma cells and primitive reticulum cells. The relation between clinical symptoms and the degrees of serum hyperviscosity in Waldenstrom's rnacroglobulinemia have been discussed by Fahey and others." The beneficial effect of plasmaphoresis on hyperviscosity syndrome has been known for some time and was well demonstrated in our patient.'* The efficacy of chlorarnbucil therapy is documented by McCallister and others.7*8~10*13~14 Relapse frequently occurred following discontinuation of chlorambucil with inability in some cases to induce a second remission when the drug is readrninistered.8 In the present case, somewhat over two years of continuous chlorambucil therapy has resulted in abolition of symptoms, control of the hyperviscosity syndrome, resolution of the hepatosplenomegaly, decrease in the size of the pulmonary mass and disappearance of the funduscopic abnormalities. sharp Y descent of the V waves. The chest showed decreased expansion and bilateral diffuse rales. The first and sewnd heart sounds were within normal limits. Atrial and ventricular
PENTAZOCINE ADDICTION CAUSl NG ENDOCARDITIS AND EMBOLISM
describe a patient with p e n t a m h e addiction who had Her pulse rate was 106
CASE REPORT
diastolic gallops were heard at the lower left sternal border.
The patient, a 29-year-old medical technician, was first hospitalized for pulmonary embolism secondary to thrombo~hlebitis of the lower extremities. Pentazocine was used as an analgesic. Anticoagulation therapy was started with heparin, and treatment was continued with Coumadin (sodium warfarin). Heparin therapy was again administered five months later because of recurrent bouts of chest pain, dyspnea and palpitation. During this interval she had started taking pentazocine of her own accord, using first oral, intramuscular and later intravenous routes. Following an episode of syncope associated with dyspnea, a lung scan showed a perfusion defect in the right middle and lower lobe. She refused to have inferior vena cava ligation. After the femoral vein ligation, the chest pain ceased dramatically. Two days later, the patient began complaining of excruciating leg pain, localized to both calf and thigh areas. Several attending physicians had felt from the beginning that she had an intense psychic overlay, and a psychiatrist was consulted. With the help of hypnosis and posthypnotic suggestion, she remained relatively symptom free and did not require any analgesics for the next two weeks. Because of clashes with the therapist, she discontinued the psychotherapy and took pentozacine for relief of her constant "nagging pain" in the lens. -Over the following year her pentazocine requirements increased to 450 mg per day (intravenously). In April, 1970, the patient developed an abscess at one of the injection sites and became febrile, with temperatures ranging up to 38.8' C. Only one of the three blood cultures was positive for coagulase-positive Staphylococcus aureus. She treated herself with sodium cloxacillin for one week, with good response. In the meantime, she had begun encountering difficulties in obtaining a parenteral preparation of pentazocine for intravenous use. She started making her own pentazocine solution by dissolving the crushed tablets in saline and administering it intravenously.
In May, 1970, she developed severe pleuritic chest pain associated with dyspnea. A murmur of tricuspid insufficiency was heard for the first time. She was hospitalized and treated with lincomycin for six weeks. About 24 hours after her admission, while receiving a placebo and occasional Demerol (meperidine) therapy, she became irritable, agitated, diaphoretic and started complaining of diffuse abdominal pain. Her vital signs had remained normal. These symptoms lasted for about three days and would respond to treatment with pentazocine only. Some of the symptoms can be explained by assuming that the patient had multiple pulmonary embolism, but on the whole they were interpreted as secondary to pentazocine withdrawal. She was discharged in a relatively asymptomatic state.
Following her discharge, she began to complain of leg pains and promptly resorted to intravenous injections of crushed pentazocine tablets dissolved in saline solution. On June 26, 1970, 25 minutes after such an injmtion, she developed severe substernal pain, dyspnea and fainted. When seen in the emergency room of the hospital, she was found to be semicomatose, cold, clammy, cyanotic, diaphoretic and hyperpneic. On palpation, the blood pressure was 40 mm Hg.
Central venous pressure was 22 mm of normal saline. The arterial blood gases showed values of oxygen tension (P-) of 46 mm Hg, carbon dioxide tension, (PC-) of 18 mm Hg and a pH of 7.40. A portable chest film showed pulmonary edema. She was given digoxin, mannitol and later furosemide, heparin and assisted respiration. The patient's condition progressively improved and the next morning findings on chest x-ray film were within normal limits. An electrocardiogram showed nonspecific T wave changes over leads 2,3, aVF and from V2 to Vs. A lung scan showed a small area of decreased uptake on the right side. On her request, the patient was discharged on the third day of hospitalization. She has been doing well since her discharge, except for a mild degree of fatigue and occasional leg pains. She has consistently denied the use of pentazocine over the last two years.
This patient c o n h s the previous reports that pentazocine can become addictive. Because she was a member of the medical profession, she had easy access to pentazocine. Her conflicts a t home and in social circles made her easy prey to addiction. Repeated intravenous injections under not so ideal conditions for asepsis amply explain the right-sided endocarditis and multiple pulmonary emboli. That a pulmonary edema-like picture presented after intravenous injection of the crushed tablets dissolved in saline solution is of particular interest. T h e intravenous injection of the insoluble fdler substances present in the tablet may have caused multiple micropulmonary emboli, or the inert substances may have evoked a n allergic type of generalized alveolitis or vasculitis, giving rise t o a pulmonary edema-like picture.= The chest pain encountered soon after the injection of the crushed tablets of pentazocine has also been observed in addicts using intravenous injections of crushed tablets of methadone and amphetamine.6 This case illustrates and lends support t o the thesis that the use of pentazocine should b e avoided in persons having emotional instability and easy access to the drug, even when there is n o history of drug dependence. 
